Dr Gloria Gonzalez-Aseguinolaza, Chief Scientific Officer of Vivet Therapeutics Receives the Rosalind Franklin Society Special Award in Science
![Vivet Dr Gloria Gonzalez-Aseguinolaza received Rosalind awards](https://www.vivet-therapeutics.com/wp-content/uploads/2024/07/Vivet_Rosalind_Franklin_Award.jpg)
Paris, France, July 16, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, is delighted to announce that its Co-Founder & Chief Scientific Officer, Dr Gloria Gonzalez-Aseguinolaza, PhD, has been honored with the Rosalind Franklin Society (RFS) Special Award in Science given […]
CTX Scientific & Family Meeting on the 28 June at 13.25 CST in Itasca, Illinois!
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/06/Vivet_CTX-1024x535.gif)
As Co-founder and Chief Scientific Officer of #VivetTherapeutics, Dr @Gloria Gonzalez-Aseguinolaza will be presenting 📢 at the upcoming #CTX Scientific & Family Meeting
Characteristics of patients with Wilson Disease in the United States: An insurance claims database study
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/06/1718787957594-1.jpg-Photos-1.jpg)
We are delighted to share our findings in a peer reviewed paper published in the World Journal of Hepatology, titled ‘Characteristics of patients with Wilson Disease in the United States: An insurance claims database study.’
Vivet Therapeutics presents interim data on its Phase 1/2 GATEWAY trial for the Treatment of Wilson Disease at EASL Congress 2024
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/06/EASL-poster-1024x535.gif)
Vivet Therapeutics Presents Interim Data from its Phase 1/2 GATEWAY Trial for the Treatment of Wilson Disease at EASL Congress 2024 VTX-801 increased ceruloplasmin ferroxidase activity and improved liver histology
EASL Congress 2024, the home of Hepatology, from 5-8 June in Milan, Italy
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/06/EASL-Attendance_FINAL-1024x535.gif)
🎓Are you attending the upcoming @EASL Congress 2024, the home of Hepatology, from 5-8 June in Milan, Italy! Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team
Study on Treatment of Wilson Disease in Japan Published in Japanese Journal of Gastroenterology and Hepatology
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/05/Japanese-JGH-Publication-1024x535.gif)
Paris, France, May 30, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders,
4th Annual Gene Therapy Patient Engagement Summit
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/05/Vivet_Gene-Therapy-Patient_SV-1024x535.gif)
Join Sonia VALERO, Head of Clinical Operations and Patient Advocacy Representative at Vivet Therapeutics’ at the 4th Annual Gene Therapy Patient Engagement Summit in Boston, 29-31 May!
5th Annual Gene Therapy Analytical Development Europe Summit
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/05/Vivet_GT-Euorpe-Summit_London-1024x535.gif)
Join us in London next week at the 5th Annual Gene Therapy Analytical Development Europe Summit, 22-24 May, where our Chief Operating Officer, @Anne Douar will be participating in a panel discussion
Genome Regulation and Cellular Fates in Homeostasis and Disease conference
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/05/Vivet_GenomeReg_RT-1024x535.gif)
📢 Listen in as @Vivet Therapeutics Co-founder and Chief Scientific Officer, @Gloria Gonzalez-Aseguinolaza participates in a round table discussion at the Genome Regulation and Cellular Fates in Homeostasis and Disease conference in Madrid from 13 – 14 May.
BioEquity Europe 2024, from 12 – 14 May in San Sebastian, Spain!
![](https://www.vivet-therapeutics.com/wp-content/uploads/2024/05/BioEquity-Post-1-1024x535.gif)
Don’t miss the opportunity to connect with our CEO @Jean-Philippe Combal & General Counsel & Head of Finance @Susan Coles at #BioEquity Europe 2024, from 12 – 14 May in San Sebastian, Spain!